Stuart Poulton, EVP, Chief Development Officer: Karyopharm Therapeutics KPTI Sell · Filed 02/19

Trade details

Type: Insider sale
Amount: $3,262.14
Shares · price: 378 sh · $8.63 a share
Held after: 99,429 sh
Stock: Karyopharm Therapeutics KPTI
Person: Stuart PoultonEVP, Chief Development Officer
Trade date: 26/02/17
Filed: 26/02/19
Days to filing: 2 days

Sold 0.4% of holdings

Share of holding sold: 0.4%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 01/18~03/19

Stuart Poulton's recent trades

Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,829
403 sh
$3,829
Filed 05/15
Traded 05/14
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$48K
5,101 sh
$48K
Filed 03/03
Traded 03/02
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,578
401 sh
$2,578
Filed 25/09/16
Traded 25/09/15
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$835
191 sh
$835
Filed 25/07/30
Traded 25/07/29
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$22.3K
3,548 sh
$22.3K
Filed 25/03/06
Traded 25/03/04